Wilcox, Christopher S.

Sotagliflozin in patients with diabetes and recent worsening heart failure

Bhatt, D. L., Szarek, M., Steg, P. G., Cannon, C. P., Leiter, L. A., McGuire, D. K., Lewis, J. B., Riddle, M. C., Voors, A. A., Metra, M., et al. (2021) · New England Journal of Medicine

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 1,868

Renal Autoregulation in Health and Disease

Carlström, M., Wilcox, C. S., & Arendshorst, W. J. (2015) · Physiological Reviews

Renin-Angiotensin System StudiesBlood Pressure and Hypertension Studies

Cited by 485

A Mouse Model of Angiotensin II Slow Pressor Response: Role of Oxidative Stress

Kawada, N., Imai, E., Karber, A., Welch, W. J., & Wilcox, C. S. (2002) · Journal of the American Society of Nephrology

Renin-Angiotensin System StudiesEicosanoids and Hypertension Pharmacology

Cited by 195

Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors

Wilcox, C. S. (2020) · Hypertension

Diabetes Treatment and ManagementBlood Pressure and Hypertension Studies

Cited by 167

Interaction between the sodium-glucose-linked transporter 2 inhibitor dapagliflozin and the loop diuretic bumetanide in normal human subjects

Wilcox, C. S., Shen, W., Boulton, D. W., Leslie, B. R., & Griffen, S. C. (2018) · Journal of the American Heart Association

Diabetes Treatment and ManagementIon Transport and Channel Regulation

Cited by 139